Unexpected Race-Based Findings in Novel Prostate Cancer Study

(MedPage Today) -- Black men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (Zytiga) plus prednisone had similar survival outcomes but more toxicity compared with white men, a multicenter prospective...